Crohn Disease Diagnostics & Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global Crohn's Disease Market Trends and is Segmented by Diagnostics (Blood Test, Fecal Test, Colonoscopy, Flexible Sigmoidoscopy, Computerized Tomography, Magnetic Resonance Imaging, Capsule Endoscopy, Other Diagnostic Tests), Treatment (Medication (Anti-inflammatory Agents, Immunosuppressants, Analgesics and Antipyretics, Other Medications), Surgery), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The report offers the market sizes and forecasts in terms of value in USD million for the above segments.

Crohn Disease Diagnostics & Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Crohn's Disease Diagnostics and Therapeutics Market Size

crohns disease diagnostic and therapeutic market-market summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 3.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

Crohn's Disease Diagnostic and Therapeutic Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Crohn's Disease Diagnostic and Therapeutic Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Crohn's Disease Diagnostics and Therapeutics Market Analysis

The Crohn's Disease Diagnostic and Therapeutic Market is expected to register a CAGR of 3.1% during the forecast period.

With the rise in COVID-19, the prevalence of other related complications also increased. According to a report by the SECURE-IBD database in January 2022, adverse COVID-19 outcomes were associated with age and other co-morbidities among patients with IBD. The novel severe acute respiratory syndrome-related coronavirus activated innate and adaptive immune responses upon entering the gastrointestinal tract. The study shows IBD patients' inflammatory reactions may cause intestinal damage. Also, a research article published in the Journal of Crohn and Colitis in March 2020 showed that IBD patients undertaking immune suppressors are associated with a greater risk of infections, even though there is no evidence to suggest that COVID-19 affects IBD patients more commonly than the general population. According to a review article in the World Journal of Gastroenterology in October 2020, it was comprehended that many COVID-19 patients were found to develop gastrointestinal complaints. Thus, there is an increasing demand for the Crohn's disease diagnostics and therapeutics market to manage further complications that could develop due to COVID-19.

The increasing occurrence of Crohn's disease is the primary driver predicted to boost the growth of the market. According to a report by the CDC published on World IBD Day in April 2021, the number of people affected by IBD is around 7 million worldwide. The report also stated that the rate of prevalence of the disease significantly increased during the last two decades. The prevalence of chronic health conditions such as cancer, arthritis, migraine, and other cardiovascular, respiratory, kidney, and liver diseases are higher in IBD patients than in non-IBD patients. In the older population (66 years and above), patients with IBD were more susceptible to hospitalization for hip fractures. Also, they were found to have 30-day readmissions, and more extended hospital stays. Studies on the treatment of IBD for the prevention of such instances are a great boost to the development of the market during the forecast period.

The increasing awareness of Crohn's disease, coupled with rising initiatives by regulatory bodies to develop novel treatment options, is expected to provide the market studied with high growth potential.

Crohn's Disease Diagnostics and Therapeutics Industry Overview

The Crohn's disease diagnostics and therapeutics market has growth opportunities in developing and developed nations. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some major market players include Pfizer Inc., Janssen Biotech Inc., GeneTech, Celgene Corporation, AbbVie Inc., and others.

Crohn's Disease Diagnostics and Therapeutics Market Leaders

  1. Abbvie Inc.

  2. Celgene Corporation

  3. GeneTech

  4. Janssen Biotech Inc.

  5. Pfizer Inc

  6. *Disclaimer: Major Players sorted in no particular order
crohns disease diagnostic and therapeutic market
Need More Details on Market Players and Competiters?
Download PDF

Crohn's Disease Diagnostics and Therapeutics Market News

  • April 2022: Microbiotica received project funding from the Crohn's and Colitis Foundation as a part of their inflammatory bowel disease ventures program for the development of therapies to treat inflammatory bowel disease.
  • April 2022: Engitix collaborated with Takeda to expand an existing agreement to include the discovery and development of novel therapeutics for fibrostenotic inflammatory bowel disease, including Crohn's disease.

Crohn's Disease Diagnostics and Therapeutics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Multiple Symptoms Associated with the Disease Requiring Individual Therapeutic Attention
    • 4.2.2 Demand for Prompt Diagnosis
    • 4.2.3 Affected Population Increasing with Time
  • 4.3 Market Restraints
    • 4.3.1 No Specific Treatment or Drug Available in the Market
    • 4.3.2 Lack of Awareness Among People and Symptom Similarity with Other Gastrointestinal Diseases
    • 4.3.3 Lack of Cost-effective Treatment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Diagnostics
    • 5.1.1 Blood Test
    • 5.1.2 Fecal Test
    • 5.1.3 Colonoscopy
    • 5.1.4 Flexible Sigmoidoscopy
    • 5.1.5 Computerised Tomography
    • 5.1.6 Magnetic Resonance Imaging
    • 5.1.7 Other Diagnostic Tests
  • 5.2 By Treatment
    • 5.2.1 Medication
    • 5.2.1.1 Anti-inflammatory Agents
    • 5.2.1.2 Immunosuppressants
    • 5.2.1.3 Analgesics and Antipyretics
    • 5.2.1.4 Other Medications
    • 5.2.2 Surgery
  • 5.3 By Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbvie Inc.
    • 6.1.2 Celgene Corporation
    • 6.1.3 Genetech
    • 6.1.4 Johnson & Johnson
    • 6.1.5 Pfizer Inc.
    • 6.1.6 Prometheus Laboratories Inc. (Nestle)
    • 6.1.7 Salix Pharmaceuticals Inc. (Valeant Pharmaceuticals)
    • 6.1.8 Takeda's Pharmaceutical Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Crohn's Disease Diagnostics and Therapeutics Industry Segmentation

Crohn's disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from the mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors in genetically predisposed individuals.

The Crohn's disease diagnostics and therapeutics market is segmented by diagnostics (blood test, fecal test, colonoscopy, flexible sigmoidoscopy, computerized tomography, magnetic resonance imaging, capsule endoscopy, other diagnostic tests), treatment (medication (anti-inflammatory agents, immunosuppressants, analgesics and antipyretics, other medications), surgery), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the market sizes and forecasts in terms of value in USD million for the above segments.

By Diagnostics Blood Test
Fecal Test
Colonoscopy
Flexible Sigmoidoscopy
Computerised Tomography
Magnetic Resonance Imaging
Other Diagnostic Tests
By Treatment Medication Anti-inflammatory Agents
Immunosuppressants
Analgesics and Antipyretics
Other Medications
Surgery
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Crohn's Disease Diagnostics and Therapeutics Market Research FAQs

What is the current Crohn's Disease Diagnostic and Therapeutic Market size?

The Crohn's Disease Diagnostic and Therapeutic Market is projected to register a CAGR of 3.1% during the forecast period (2025-2030)

Who are the key players in Crohn's Disease Diagnostic and Therapeutic Market?

Abbvie Inc., Celgene Corporation, GeneTech, Janssen Biotech Inc. and Pfizer Inc are the major companies operating in the Crohn's Disease Diagnostic and Therapeutic Market.

Which is the fastest growing region in Crohn's Disease Diagnostic and Therapeutic Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Crohn's Disease Diagnostic and Therapeutic Market?

In 2025, the North America accounts for the largest market share in Crohn's Disease Diagnostic and Therapeutic Market.

What years does this Crohn's Disease Diagnostic and Therapeutic Market cover?

The report covers the Crohn's Disease Diagnostic and Therapeutic Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Crohn's Disease Diagnostic and Therapeutic Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Road Safety Industry Report

Statistics for the 2025 Crohn's Disease Diagnostic and Therapeutic market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Crohn's Disease Diagnostic and Therapeutic analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.